Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial

Emma Guttman-Yassky^*, Jonathan I. Silverberg, Diamant Thaçi, Kim A. Papp, Sonja Ständer, Lisa A. Beck, Brian S. Kim, Xiaofei Hu, Jianzhong Liu, Brian M. Calimlim, Namita Vigna, Jameson T. Crowley, Henrique D. Teixeira, Jacob P. Thyssen